-+ 0.00%
-+ 0.00%
-+ 0.00%

Altimmune launches underwritten public offering with common stock, warrants

PUBT·04/22/2026 20:30:48
Listen to the news
Altimmune launches underwritten public offering with common stock, warrants
  • Altimmune launched an underwritten public offering of common stock with accompanying common stock warrants.
  • Some investors can buy pre-funded warrants in lieu of common stock, paired with common stock warrants.
  • Net proceeds are earmarked for upcoming Phase 3 MASH trial funding.
  • Remaining proceeds will support working capital, general corporate purposes.
  • Leerink Partners, Barclays will run books; Titan Partners will act as co-bookrunner.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Altimmune Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604221619PRIMZONEFULLFEED9695295) on April 22, 2026, and is solely responsible for the information contained therein.